125 related articles for article (PubMed ID: 65215)
21. Studies on lymphokine activity in concanavalin A-stimulated lymphocyte supernatants using the macrophage-electrophoretic-mobility-test (MEM-test).
Kotzsch M; Grossmann H; Irmscher J; Müller M
Exp Pathol; 1982; 21(3):143-8. PubMed ID: 7117487
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
Shenton BK; Jenssen HL; Werner H; Field EJ
J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
[TBL] [Abstract][Full Text] [Related]
23. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
[TBL] [Abstract][Full Text] [Related]
24. Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigs.
Flavell DJ; Goepel J; Wilson AP; Potter CW
Br J Cancer; 1979 Sep; 40(3):424-36. PubMed ID: 92328
[TBL] [Abstract][Full Text] [Related]
25. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
[TBL] [Abstract][Full Text] [Related]
26. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
Cerni CH; Micksche M
Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
[TBL] [Abstract][Full Text] [Related]
27. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
28. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
Malkovský M; Bubeník J; Holán V; Hasek M
Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
[TBL] [Abstract][Full Text] [Related]
29. Determination of cell mediated immunity against tumour associated antigens in patients of ENT.
Nowak R; Günther M; Jenssen HL; Seyfarth M; Werner H; Putzke HP
Acta Otolaryngol; 1979; 87(3-4):400-3. PubMed ID: 87106
[TBL] [Abstract][Full Text] [Related]
30. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
Rawlins GA; Wood JM; Bagshawe KD
Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
[TBL] [Abstract][Full Text] [Related]
31. KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
Muhrer KH; Link KH
Cancer Detect Prev; 1983; 6(1-2):101-6. PubMed ID: 6883371
[TBL] [Abstract][Full Text] [Related]
32. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
[TBL] [Abstract][Full Text] [Related]
33. Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected data.
Kast RE
Med Hypotheses; 1980 Jan; 6(1):63-72. PubMed ID: 6155596
[TBL] [Abstract][Full Text] [Related]
34. Cellular sensitization in tumor-bearing mice to soluble extracts from normal and malignant tissues. I. Common and individually distinct antigens as detected by electrophoretic mobility (EM) test.
Werner H; Jenssen HL; Köhler H; von Broen B; Pasternak G; Thuy LT; Schlott B; Pasternak L
Eur J Cancer (1965); 1978 May; 14(5):485-90. PubMed ID: 77224
[No Abstract] [Full Text] [Related]
35. A human lymphokine released by mononuclear blood cells upon contact with CEA.
Müller M; Grossmann H; Wagner H; Irmscher J; Kotzsch M
Immunol Lett; 1986 Mar; 12(2-3):159-64. PubMed ID: 3721537
[TBL] [Abstract][Full Text] [Related]
36. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
[TBL] [Abstract][Full Text] [Related]
37. [In vitro reaction of lymph node cells of mice to protein and cell-bound antigens. A study with the macrophage electrophoretic mobility test ].
Schäffner H
Allerg Immunol (Leipz); 1981; 27(3):145-52. PubMed ID: 6181671
[TBL] [Abstract][Full Text] [Related]
38. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) test.
Pasternak L; Jenssen HL; Köhler H; Pasternak G
Eur J Cancer (1965); 1976 May; 12(5):389-93. PubMed ID: 954796
[No Abstract] [Full Text] [Related]
40. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.
Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S
J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
